CFM
ORKA

Compass Financial Management’s Oruka Therapeutics ORKA Stock Holding History

Compass Financial Management’s Portfolio ORKA Stock Details ORKA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.73K Buy
+38
New +$2.53K ﹤0.01% 1238

Other funds holding ORKA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Compass Financial Management's ORKA Position: Q2 2026 in Review

Compass Financial Management opened a new position in Oruka Therapeutics (ORKA) in Q2 2026: 38 shares worth $3.73K. The stake represents ﹤0.01% of the portfolio and ranks #1238 among its holdings.

237 funds tracked by Wall St. Rank hold ORKA as of Q2 2026.

  • Compass Financial Management held 38 shares of Oruka Therapeutics worth $3.73K as of Q2 2026.
  • Oruka Therapeutics was a new Compass Financial Management position in Q2 2026.
  • Oruka Therapeutics made up ﹤0.01% of Compass Financial Management's portfolio in Q2 2026, its #1238 holding.
  • 237 funds tracked by Wall St. Rank held Oruka Therapeutics as of Q2 2026.

Based on Compass Financial Management's 13F filing for Q2 2026, filed 12 Aug 2026.